1-4 of 4
Peter Bugelski
Close
Sort by
Journal Articles

Cross Laboratory Validation of An In Vitro Screen for Cytokine Release Syndrome

Gregory Bannish, Ph.D., Dorie Makropoulos, Meredith Perpetua, BS, Gareth Thomas, BSc, (Hons), Simon Bate, PhD, Mindi Walker, Ph.D., Peter Bugelski, PhD
Journal: Blood
Blood (2010) 116 (21): 2778.
https://doi.org/10.1182/blood.V116.21.2778.2778
Published: 2010
Journal Articles

Activity of CNTO 530 in a Murine Model of Sickle Cell Anemia.

Dorie Makropoulos, BS, MT, Ram Achuthanandam, PhD, Patricia Rafferty, BA, HT, (ASCP), Denise Chroscinski, Kerry Brosnan, Lawrence Ogunkua, Andrew Miller, Justin Avery, Mindi Walker, PhD, Peter Bugelski, PhD
Journal: Blood
Blood (2009) 114 (22): 4606.
https://doi.org/10.1182/blood.V114.22.4606.4606
Published: 2009
Journal Articles

Pharmacodynamics of CNTO 530 in a Murine Model of B-Thalassemia

Dorie A Makropoulos, Renold J Capocasale, Ram Achuthanandam, Krista Wilson, Amy Volk, Peter Bugelski
Journal: Blood
Blood (2008) 112 (11): 3892.
https://doi.org/10.1182/blood.V112.11.3892.3892
Published: 2008
Journal Articles

Pharmacokinetics and Pharmacodynamics of CNTO 528, a Novel Erythropoietin Receptor Agonist in Normal and Anemic Rats.

Peter Bugelski, PhD, T. Nesspor, T. Spinka-Doms, D. Makropoulos, E. Eirikis, J. Fisher, A. Volk, K. Shamberger, I. James, P. Fisher, C. Pool, H. Jang, B. Miller, C. Huang, G. Heavner, D. Knight, J. Ghrayeb, B. Scallon
Journal: Blood
Blood (2005) 106 (11): 4261.
https://doi.org/10.1182/blood.V106.11.4261.4261
Published: 2005